Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FKBP1A | P62942 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7251345 | 0.93 | FKBP1A (0.88) | FKBP1A | |
| SCHEMBL5966167 | 0.92 | FKBP1A (1.00) | FKBP1A | |
| SCHEMBL4676222 | 0.88 | FKBP1A (0.79) | FKBP1A | |
| SCHEMBL7396367 | 0.87 | FKBP1A (1.00) | FKBP1A | |
| SCHEMBL5834555 | 0.87 | FKBP1A (1.00) | FKBP1A | |
| SCHEMBL7252741 | 0.84 | FKBP1A (0.73) | FKBP1A | |
| SCHEMBL7246218 | 0.84 | FKBP1A (0.73) | FKBP1A | |
| SCHEMBL7252100 | 0.84 | FKBP1A (0.73) | FKBP1A | |
| SCHEMBL21471511 | 0.84 | FKBP1A (0.73) | FKBP1A | |
| SCHEMBL5966173 | 0.84 | FKBP1A (1.00) | FKBP1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6376517-B1 | FOR TREATING VISION LOSS, PREVENTING VISION DEGENERATION, AND PROMOTING VISION REGENERATION (?NEOPSIS?) | GPI NIL HOLDINGS, INC. | 2002-04-23 | — | — | US | claimed |
| EP-0777478-B1 | INHIBITORS OF ROTAMASE ENZYME ACTIVITY | GUILFORD PHARM INC (US) | 2001-11-07 | — | — | EP | claimed |
| US-20010036947-A1 | Pipecolic acid derivative hair growth compositions and uses | GPI NIL HOLDINGS, INC. (US) | 2001-11-01 | — | — | US | claimed |
| US-6187784-B1 | ALOPECIA TREATMENT; FKBP-IMMUNOPHILIN AFFINITY | GPI NIL HOLDINGS, INC. | 2001-02-13 | — | — | US | claimed |
| US-5843960-A | Inhibitors of rotamase enzyme activity | GPI NIL HOLDINGS, INC. (US) | 1998-12-01 | — | — | US | claimed |
| US-5696135-A | Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth | GPI NIL HOLDINGS, INC. (US) | 1997-12-09 | — | — | US | claimed |
| US-6376517-B1 | FOR TREATING VISION LOSS, PREVENTING VISION DEGENERATION, AND PROMOTING VISION REGENERATION (?NEOPSIS?) | GPI NIL HOLDINGS, INC. | 2002-04-23 | — | — | US | disclosed |
| US-6187784-B1 | ALOPECIA TREATMENT; FKBP-IMMUNOPHILIN AFFINITY | GPI NIL HOLDINGS, INC. | 2001-02-13 | — | — | US | disclosed |
| US-5696135-A | Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth | GPI NIL HOLDINGS, INC. (US) | 1997-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010036947-A1 | Pipecolic acid derivative hair growth compositions and uses | PIP5K1C, PIP4K2C, PIP5K1A | FKBP1A 510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.